Clearer questions. More informed care.Our commercial disclosure
Panda BearA PATIENT’S FIELD GUIDE
Menu

Reference field note

Tesamorelin

A reference record with its source links, an editorial reading note, and questions to carry forward.

Aliases: Egrifta WR

Status
Approved product
Evidence label
Randomized evidence
Index topics
Hormones
Status as of

The record

Recorded fields

Mechanism
Stimulates growth-hormone release.
Evidence
A randomized trial measured visceral fat.
Limitations
Not for weight management.
Safety
Active malignancy is a contraindication.
Route context
Specified subcutaneous formulation.
Approval scope
Egrifta WR addresses excess abdominal fat in adults with HIV-associated lipodystrophy.

Pause and consider

A reading note

A qualification belongs beside the claim it changes. When making a short note from a longer passage, keep words expressing uncertainty or conditions attached to the relevant sentence. If the passage contains several claims, identify which the qualification concerns rather than spreading it across everything or dropping it entirely. Read your note back with the qualification removed: if the meaning becomes stronger or broader, those words are doing necessary work. A concise note should preserve that work, even when background detail is shortened. Otherwise, your later question may begin from a claim the passage did not make.

Questions to carry forward

  • Which specific claim does this qualification narrow or make conditional?
  • Would removing these words make my note stronger than the passage I read?
  • Can I shorten the background while preserving the condition that gives the claim its scope?

Follow the record

References

Prepared by the Panda Bear editorial team. Educational information; no independent medical review is claimed.